Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction.

Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ.

Am J Manag Care. 2007 Aug;13(8):445-52.

2.
3.

Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.

Dormuth CR, Glynn RJ, Neumann P, Maclure M, Brookhart AM, Schneeweiss S.

Clin Ther. 2006 Jun;28(6):964-78; discussion 962-3.

PMID:
16860179
4.

Beta-blocker initiation and adherence after hospitalization for acute myocardial infarction.

Maio V, Marino M, Robeson M, Gagne JJ.

Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):438-45. doi: 10.1177/1741826710389401.

PMID:
21450641
5.

Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers.

Zhang D, Carlson AM, Gleason PP, Schondelmeyer SW, Schommer JC, Dowd BE, Heaton AH.

J Manag Care Pharm. 2007 Oct;13(8):664-76.

6.

Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.

Cole JA, Norman H, Weatherby LB, Walker AM.

Pharmacotherapy. 2006 Aug;26(8):1157-64.

PMID:
16863491
7.

Associations between prescription copayment levels and β-blocker medication adherence in commercially insured heart failure patients 50 years and older.

Patterson ME, Blalock SJ, Smith AJ, Murray MD.

Clin Ther. 2011 May;33(5):608-16. doi: 10.1016/j.clinthera.2011.04.022.

PMID:
21665045
9.

Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.

Wang PS, Patrick AR, Dormuth C, Maclure M, Avorn J, Canning CF, Schneeweiss S.

J Ment Health Policy Econ. 2010 Mar;13(1):37-44.

10.

Health and economic benefits of increased beta-blocker use following myocardial infarction.

Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, Williams LW, Weinstein MC, Goldman L.

JAMA. 2000 Dec 6;284(21):2748-54.

PMID:
11105180
11.

Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications.

Dormuth CR, Maclure M, Glynn RJ, Neumann P, Brookhart AM, Schneeweiss S.

Clin Ther. 2008;30 Spec No:1038-50. doi: 10.1016/j.clinthera.2008.06.003.

12.

A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.

Smith DH, Kramer JM, Perrin N, Platt R, Roblin DW, Lane K, Goodman M, Nelson WW, Yang X, Soumerai SB.

Arch Intern Med. 2008 Mar 10;168(5):477-83; discussion 483; quiz 447. doi: 10.1001/archinternmed.2007.132.

PMID:
18332291
13.

Outpatient adherence to beta-blocker therapy after acute myocardial infarction.

Butler J, Arbogast PG, BeLue R, Daugherty J, Jain MK, Ray WA, Griffin MR.

J Am Coll Cardiol. 2002 Nov 6;40(9):1589-95.

14.

Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.

Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH.

Am Heart J. 2008 Jul;156(1):31-6. doi: 10.1016/j.ahj.2008.03.021.

15.

National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.

Kramer JM, Hammill B, Anstrom KJ, Fetterolf D, Snyder R, Charde JP, Hoffman BS, Allen LaPointe N, Peterson E.

Am Heart J. 2006 Sep;152(3):454.e1-8.

PMID:
16923412
16.

Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications.

Dormuth CR, Neumann P, Maclure M, Glynn RJ, Schneeweiss S.

Med Care. 2009 May;47(5):508-16. doi: 10.1097/MLR.0b013e318190d482.

17.

Full coverage for preventive medications after myocardial infarction.

Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH; Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial..

N Engl J Med. 2011 Dec 1;365(22):2088-97. doi: 10.1056/NEJMsa1107913.

18.

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA.

JAMA. 1998 Aug 19;280(7):623-9. Erratum in: JAMA 1999 Jan 6;281(1):37.

PMID:
9718054
19.

Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.

Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L.

JAMA. 1997 Jan 8;277(2):115-21.

PMID:
8990335
20.

Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?

Wei L, Flynn R, Murray GD, MacDonald TM.

Pharmacoepidemiol Drug Saf. 2004 Nov;13(11):761-6.

PMID:
15386713
Items per page

Supplemental Content

Support Center